Rare Diseases: Drugs
Commons · Question 77062 · Tabled 15 Sep 2025 · Department of Health and Social Care · Official record
Answered 13 Oct 2025
Question
Asked by Jim Shannon
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the requirement in the NHS England Commercial Framework for New Medicines for medicines to provide value at-or-below NICE’s cost-effectiveness
Answer
Answered by Zubir Ahmed, 13 Oct 2025
I refer the Hon. Member to the answers my Rt Hon. Friend, the Minister of State for Health gave on 1 September 2025 to Questions 69240, 69241, and 69242.